Inhibition of tumour invasion and angiogenesis by epigallocatechin gallate (EGCG), a major component of green tea.
about
Recent advances on tea polyphenolsDisrupting antibiotic resistance propagation by inhibiting the conjugative DNA relaxaseEvasion of anti-growth signaling: A key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds.Identifying new small molecule anti-invasive compounds for glioma treatmentTherapeutic targeting of replicative immortalityA multi-targeted approach to suppress tumor-promoting inflammationCan DCEMRI assess the effect of green tea on the angiogenic properties of rodent prostate tumors?Activity of green tea polyphenol epigallocatechin-3-gallate against ovarian carcinoma cell lines(-)-Epigallocatechin-3-gallate inhibits growth of gastric cancer by reducing VEGF production and angiogenesis.Catechins induced acute promyelocytic leukemia cell apoptosis and triggered PML-RARα oncoprotein degradation.EGCG inhibits proliferation, invasiveness and tumor growth by up-regulation of adhesion molecules, suppression of gelatinases activity, and induction of apoptosis in nasopharyngeal carcinoma cells.Protective mechanisms of green tea polyphenols in skinEffects of long-term tea polyphenols consumption on hepatic microsomal drug-metabolizing enzymes and liver function in Wistar rats.Catechins and Their Therapeutic Benefits to Inflammatory Bowel Disease.A 3-day EGCG-supplementation reduces interstitial lactate concentration in skeletal muscle of overweight subjects.Possible role for green tea in ovarian cancer prevention.Theaflavin-3, 3'-digallate decreases human ovarian carcinoma OVCAR-3 cell-induced angiogenesis via Akt and Notch-1 pathways, not via MAPK pathways.Effect of dietary green tea extract and aerosolized difluoromethylornithine during lung tumor progression in A/J strain miceA green tea component suppresses posttranslational expression of basic fibroblast growth factor in colorectal cancer.Molecular mechanisms of green tea polyphenolsEarly transcriptional pattern of angiogenesis induced by EGCG treatment in cervical tumour cells.Green tea catechins: a fresh flavor to anticancer therapy.(-)-Epigallocatechin-3-gallate inhibits nasopharyngeal cancer stem cell self-renewal and migration and reverses the epithelial-mesenchymal transition via NF-κB p65 inactivation.Modulation of tumor microenvironment by chemopreventive natural products.Comparison of a pair of synthetic tea-catechin-derived epimers: synthesis, antifolate activity, and tyrosinase-mediated activation in melanoma.Effects of green tea polyphenol on methylation status of RECK gene and cancer cell invasion in oral squamous cell carcinoma cellsDifferential proteomic analysis reveals that EGCG inhibits HDGF and activates apoptosis to increase the sensitivity of non-small cells lung cancer to chemotherapy.Formulation and characterization of EGCG for the treatment of superficial bladder cancer.The modulation of endothelial cell gene expression by green tea polyphenol-EGCG.Binding of natural and synthetic polyphenols to human dihydrofolate reductase.Analysis of catechin content of commercial green tea products.Induction of G1 cell cycle arrest in human umbilical vein endothelial cells by flavone's inhibition of the extracellular signal regulated kinase cascade.TEAVIGO (epigallocatechin gallate) supplementation prevents obesity in rodents by reducing adipose tissue mass.Effect of new antioxidant cysteinyl-flavanol conjugates on skin cancer cells.Mechanism of inhibition of wt-dihydrofolate reductase from E. coli by tea epigallocatechin-gallate.Effect of dietary epigallocatechin-3-gallate on cytochrome P450 2E1-dependent alcoholic liver damage: enhancement of fatty acid oxidation.Transient receptor potential vanilloid type 1 is vital for (-)-epigallocatechin-3-gallate mediated activation of endothelial nitric oxide synthase.Taking the vehicle out of drug delivery.EGCG ameliorates the suppression of long-term potentiation induced by ischemia at the Schaffer collateral-CA1 synapse in the rat.Neurorestorative effects of epigallocatechin-3-Gallate on cognitive function in a chronic cerebral hypoperfusion rat model.
P2860
Q24616890-5A36E568-13E6-4DE3-889B-A08D0060BA95Q24674141-2EB98B5A-0EC5-4507-A21C-CB50D0CAA135Q26827810-7096B4D1-6A5D-4D81-9FE1-B9D142DA3C58Q27025151-23471B3B-7031-4DE0-A79E-829EDF8668B0Q27027457-64946CF1-6A73-44FE-AF1E-A6074D8A54ECQ28393278-1A990B25-0885-4D66-B421-86DA98EBEDF1Q33489265-10BB97FB-AF35-4435-AC42-1C45A5058DAAQ33746776-2A4C3DDE-408F-4AA7-BE7C-FFC6427EFD4CQ34099507-C6B1AFAB-F258-4E9E-90AD-E1E4D9A227E6Q34339982-C381879E-9137-41D9-B9E0-F1A797077E53Q35138905-B6E2FE2C-7360-4EEC-9CF1-52C3E8ECFC69Q36077489-30FF50A7-F5BE-42E4-B81E-00BA92385565Q36180517-6D913C86-9E80-45B7-B86E-C57EDC2DFF9FQ36320770-9F1A03DF-4A5B-4E49-8B31-220071460610Q36356726-C5EAC3E5-9A8E-4669-A607-FB328226ACECQ36429621-21FC7C4A-EEFC-42FA-A373-01BDB3995E7BQ36525391-428B8453-8DD9-4FD4-9901-CA69181D676BQ36837995-223EB315-8C50-4EC2-BBE3-B56A46524D2DQ36925977-D08CD37A-3BC1-4D38-8F57-A4C1ABCDA554Q37161937-25128EE3-50D1-4775-86D7-AFC650582024Q37294809-FAE5BAAA-8EA5-4FDE-8609-94219ECFCB96Q38147993-4309E690-5222-4C46-9469-5752BF0553A4Q38930822-E23BE5AE-8275-4D06-871E-9BEDE5352C2CQ39391322-461FD55B-3CE8-45F2-A039-FD4BADD99499Q39596101-B39D3F51-48E1-4458-82CE-F407CAE81734Q39956136-F5A33826-5E0F-4119-8E5C-6281F0E28042Q40736209-3CE51B65-0F8B-4DBD-A263-475CFA6EBF12Q40979874-C1B3BBA2-CED5-457D-A546-9C524CBC55C1Q41769428-5656843F-9A7A-4259-865B-D9E0C7418570Q42644973-35428A22-78C4-40FF-96BF-AA07E9D22A5EQ44995280-6648F1B7-5162-41BC-B827-B108BCC49117Q45119734-43157330-012D-4915-9BDE-6E34203C1147Q45285862-FD8C325C-4B3B-4680-AD5B-4A07C8581393Q46624047-B349D689-A441-489C-B547-617F2AF8A182Q46794953-4CC992A6-CA07-45CD-BFB2-F51A12B21DD1Q46856678-D5577036-D336-47FC-A651-D01E49A5FE5CQ50284110-C5CDF1BE-5B4F-4C07-8071-0DCF202CC856Q50437586-C6C7039B-2670-4A6F-B03F-B230F2472216Q50507980-5A2B6045-02D9-4D53-9185-F05CE013CAAAQ50520196-27CE646E-C5BF-42DA-A6A9-5452CC77ABC7
P2860
Inhibition of tumour invasion and angiogenesis by epigallocatechin gallate (EGCG), a major component of green tea.
description
2001 nî lūn-bûn
@nan
2001 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Inhibition of tumour invasion ...... major component of green tea.
@ast
Inhibition of tumour invasion ...... major component of green tea.
@en
Inhibition of tumour invasion ...... major component of green tea.
@nl
type
label
Inhibition of tumour invasion ...... major component of green tea.
@ast
Inhibition of tumour invasion ...... major component of green tea.
@en
Inhibition of tumour invasion ...... major component of green tea.
@nl
prefLabel
Inhibition of tumour invasion ...... major component of green tea.
@ast
Inhibition of tumour invasion ...... major component of green tea.
@en
Inhibition of tumour invasion ...... major component of green tea.
@nl
P2860
P1476
Inhibition of tumour invasion ...... major component of green tea.
@en
P2093
P2860
P304
P356
10.1046/J.1365-2613.2001.00205.X
P577
2001-12-01T00:00:00Z